Loading image...
Ventricular Assist Device (VAD): Lifesaving Heart Support thumbnail
Medical Devices

Ventricular Assist Device (VAD): Lifesaving Heart Support

A VAD (Ventricular Assist Device) is a mechanical pump that supports heart function for advanced heart failure. Learn how this device improves blood flow & quality of life.

Ventricular Assist Device (VAD): Lifesaving Heart Support

By Dr. Priya Sharma
23 min read
✓ Medically Reviewed

What is Ventricular Assist Device (VAD): Purpose, Procedure, Results & Costs in India

Heart disease remains a significant health challenge across India, with advanced heart failure affecting millions of lives. For patients grappling with the debilitating effects of end-stage heart failure, where the heart can no longer pump enough blood to meet the body's needs despite optimal medical therapy, hope often dwindles. However, modern medical technology offers a lifeline: the Ventricular Assist Device (VAD).

What is Ventricular Assist Device (VAD)?

A Ventricular Assist Device (VAD) is a mechanical pump designed to support heart function and blood flow in people with weakened hearts. It’s not a replacement for the heart itself, but rather an assistive device that helps one or both of the heart's main pumping chambers (ventricles) circulate blood more effectively throughout the body. Imagine a sophisticated, miniature engine that takes over some of the heavy lifting for a tired heart, ensuring vital organs receive the oxygen and nutrients they need to function.

VADs are critical lifelines for Indian patients suffering from advanced heart failure, transforming what was once a terminal diagnosis into a manageable condition with improved quality of life and extended survival. The adoption of VAD technology in India is steadily increasing, with several advanced cardiac centers across major cities now offering these complex procedures, marking a significant stride in cardiac care within the country.

These devices are primarily used when a patient's heart is too weak to adequately pump blood on its own. They are typically implanted during open-heart surgery and consist of a pump, a control unit, and batteries worn outside the body. A small cable, known as a driveline, connects the internal pump to the external components.

There are different types of VADs, depending on which part of the heart needs assistance:

  • Left Ventricular Assist Device (LVAD): This is the most common type, assisting the left ventricle, which is responsible for pumping oxygen-rich blood to the rest of the body. Most VADs referred to in general conversation are LVADs.
  • Right Ventricular Assist Device (RVAD): Less common, this device supports the right ventricle in pumping blood to the lungs.
  • Biventricular Assist Device (BiVAD): In rare cases, both ventricles may require assistance, necessitating a BiVAD.

The technology behind VADs has advanced significantly, with newer generations of devices being smaller, more durable, and offering continuous flow, which has dramatically improved patient outcomes and reduced complications. For Indian patients and their families, understanding VADs can open doors to new possibilities in the face of advanced heart failure.

Why is Ventricular Assist Device (VAD) Performed?

Ventricular Assist Devices serve a crucial role in managing end-stage heart failure, particularly for Indian patients who have exhausted other medical treatments. The decision to implant a VAD is a complex one, made after thorough evaluation by a multidisciplinary team. The primary reasons for VAD implantation fall into several key categories:

  • Bridge-to-Transplant Therapy:

    • Addressing Organ Shortage: India faces a severe shortage of donor hearts. Patients with end-stage heart failure may wait months, or even years, for a suitable heart donor. During this critical waiting period, their health can deteriorate rapidly.
    • Maintaining Stability: A VAD can keep patients alive and stable, significantly improving their physical condition and ensuring that they remain strong enough to undergo a heart transplant when a donor heart becomes available. This period can extend from several months to potentially several years.
    • Optimizing Transplant Success: By improving the patient's overall health and organ function before transplantation, VADs increase the chances of a successful transplant surgery and better post-transplant outcomes. It prevents the patient from becoming too sick to receive a transplant, a common challenge in the context of long waiting lists.
    • Psychological and Physical Benefits: Patients often experience a renewed sense of hope and a significant improvement in their quality of life, allowing them to engage in light activities and spend time with family while awaiting a donor heart.
  • Destination Therapy:

    • Long-Term Solution: For many patients, a heart transplant is not an option due to factors such as advanced age, other serious medical conditions (comorbidities), or personal choice. For these individuals, VADs serve as a long-term solution, known as destination therapy.
    • Improved Quality of Life and Survival: Destination therapy aims to significantly improve the patient's quality of life and extend their survival. Patients who were previously confined to their beds or frequently hospitalized can often regain enough strength to live active lives, participate in family events, and even return to some professional activities.
    • Shifting Paradigms: This approach has transformed the management of end-stage heart failure, moving from palliative care to life-extending and quality-enhancing treatment for a large demographic who previously had no viable options.
  • Bridge-to-Recovery Therapy:

    • Temporary Support: In some specific cases, a VAD may be implanted temporarily to support a weakened heart, allowing it to rest and recover its normal function. This is often seen in acute heart failure situations, such as after a severe heart attack (myocardial infarction), myocarditis (inflammation of the heart muscle), or peripartum cardiomyopathy (heart muscle weakness related to pregnancy).
    • Heart Regeneration: By taking over the pumping duties, the VAD reduces the workload on the native heart, providing an opportunity for the heart muscle to heal and potentially regain its strength.
    • Potential for Device Removal: If the heart recovers sufficiently, the VAD can be explanted (removed), a truly remarkable outcome where the patient no longer requires mechanical support. While rare, it represents the ultimate goal of "bridge-to-recovery."
  • Improved Circulation and Organ Function:

    • Alleviating Symptoms: Advanced heart failure leads to symptoms like extreme fatigue, severe shortness of breath, swelling (edema) in the legs and abdomen, and reduced exercise tolerance. By assisting the heart's pumping action, VADs significantly enhance blood flow to the entire body.
    • Restoring Organ Health: This improved circulation alleviates these debilitating symptoms and, crucially, enhances the functioning of other vital organs such as the kidneys, liver, and brain, which may have been impaired due to low cardiac output. Better organ function can prevent multi-organ failure, a common complication of advanced heart failure.
    • Enhanced Well-being: Patients often report increased energy levels, better appetite, improved mental clarity, and a general sense of well-being, allowing them to participate more fully in their lives.

In the Indian context, where the prevalence of heart failure is rising and access to organ transplantation is limited, VADs offer a critically important and increasingly accessible therapeutic option for patients who previously faced a bleak prognosis.

Preparation for Ventricular Assist Device (VAD)

The journey toward VAD implantation is meticulous and comprehensive, designed to ensure the patient is an ideal candidate and fully prepared for the complex surgery and subsequent lifestyle adjustments. This rigorous preparation for Indian patients typically involves a multi-stage process:

  • Extensive Medical Examination and Diagnostic Tests:

    • Cardiac Evaluation: This includes detailed Electrocardiograms (ECGs), Echocardiograms (ultrasound of the heart to assess function), Stress Tests (to evaluate heart function under exertion), Cardiac MRI/CT scans (for detailed structural and functional assessment), and Right Heart Catheterization (to measure pressures within the heart chambers and lungs). These tests precisely define the extent of heart failure and identify any other cardiac issues.
    • Organ Function Tests: Comprehensive blood tests are performed to assess the function of vital organs such as kidneys (creatinine, BUN), liver (liver enzymes), and lungs (pulmonary function tests). Electrolyte levels, blood sugar, and a complete blood count (CBC) are also crucial.
    • Infection Screening: Extensive screening for any active or dormant infections (e.g., dental infections, urinary tract infections, hepatitis, HIV) is vital, as infections can be particularly dangerous post-surgery with an implanted device.
    • Coagulation Profile: Blood clotting tests are conducted to assess the patient's risk of bleeding or clotting, critical for anticipating and managing post-operative anticoagulation.
    • Nutritional Assessment: A thorough evaluation of the patient's nutritional status is done, as malnutrition can impact recovery. Dietary counseling may be provided.
    • Other Screenings: Depending on age and medical history, prostate screenings, colonoscopies, and other general health checks may be performed to rule out any conditions that could complicate surgery or recovery.
  • Heart Failure Management and Optimization:

    • Patients often spend time in the hospital before surgery to receive intensive medical therapy to optimize their heart failure condition. This might involve intravenous diuretics to reduce fluid overload, inotropic medications to temporarily strengthen heart contractions, and careful fluid and electrolyte management.
    • The goal is to bring the patient to the best possible physiological state before surgery, reducing immediate post-operative risks.
  • Multidisciplinary Assessment and Treatment Planning:

    • VAD implantation is a team effort. A dedicated team of specialists works collaboratively to create a patient-centric treatment plan. This team typically includes:
      • Heart Failure Cardiologists: To manage the patient's heart failure and determine VAD suitability.
      • VAD Surgeons: Highly specialized cardiac surgeons who perform the implantation.
      • Cardiac Anesthesiologists: To manage anesthesia and vital signs during the complex surgery.
      • Perfusionists: Operate the heart-lung bypass machine.
      • VAD Coordinators/Nurses: Provide extensive education, training, and ongoing support for patients and families.
      • Dietitians: To ensure optimal nutrition pre- and post-surgery.
      • Physical Therapists: For pre-habilitation and post-operative rehabilitation.
      • Social Workers and Psychologists: To address the significant psychological and social challenges associated with VAD therapy.
    • This collaborative approach ensures all aspects of the patient's physical and mental health are considered.
  • Patient and Family Education and Counseling:

    • This is a cornerstone of VAD preparation. Doctors and VAD coordinators provide detailed information about:
      • The surgical procedure, its benefits, and potential risks.
      • The VAD device itself, how it functions, and the external components (controller, batteries).
      • Expected recovery process, including hospital stay, rehabilitation, and long-term care.
      • The significant lifestyle changes required, such as daily driveline care, battery management, medication adherence (especially anticoagulants), and emergency protocols.
      • The psychological impact of living with a VAD, including potential body image issues and anxiety.
    • Family members are educated extensively, as they play a crucial role as caregivers and support systems. Informed consent is obtained after all questions are thoroughly addressed.
  • Eligibility Criteria (Inclusion and Exclusion):

    • Inclusion Criteria: Patients typically need to have severe (NYHA functional class III/IV) heart failure symptoms despite optimal medical therapy, frequent hospitalizations for heart failure exacerbations, intolerance to neurohormonal antagonists, or evidence of end-organ dysfunction due to low cardiac output. They must also have a reasonable prognosis for survival with VAD.
    • Exclusion Criteria: Patients with certain conditions are generally not suitable candidates, including:
      • Irreversible kidney, liver, or severe lung disease.
      • Active systemic infections that cannot be treated.
      • Severe peripheral vascular disease.
      • Unmanaged psychiatric conditions or a history of non-compliance with medical regimens.
      • Advanced malignancy with limited life expectancy.
      • Severe blood clotting disorders that make anticoagulation too risky.
    • A careful risk-benefit analysis is performed for each individual to ensure the VAD offers a genuine improvement in prognosis and quality of life.

This exhaustive preparation phase is crucial for maximizing the safety and success of VAD implantation, particularly in the unique healthcare landscape of India.

The Ventricular Assist Device (VAD) Procedure

VAD implantation is a major, complex open-heart surgery that typically takes several hours and requires a highly skilled surgical team. Here’s a step-by-step overview of the procedure:

  1. Pre-operative Preparation:

    • Before entering the operating theatre, the patient undergoes final preparations, including shaving and sterilizing the chest area.
    • Intravenous (IV) lines are inserted for medication and fluids, and arterial and central venous lines are placed to monitor blood pressure and administer drugs during surgery.
    • A breathing tube is carefully guided into the lungs and connected to a ventilator, which will take over the patient's breathing during the procedure.
  2. Anesthesia and Cardiopulmonary Bypass Setup:

    • The patient is given general anesthesia, rendering them unconscious and pain-free throughout the surgery.
    • Once anesthetized, the surgical team proceeds to access the heart. The surgeon makes an incision down the center of the chest, carefully cuts the breastbone (sternum), and uses a retractor to open the rib cage, providing direct access to the heart.
    • A crucial step is connecting the patient to a heart-lung bypass machine (cardiopulmonary bypass). This machine temporarily takes over the functions of the heart and lungs, circulating oxygen-rich blood throughout the body while the surgical team operates on a still, bloodless heart. Medications are administered to stop the heart (cardioplegia) during this phase.
  3. VAD Implantation:

    • With the heart still and the patient on bypass, the surgeon meticulously implants the VAD.
    • LVAD (Left Ventricular Assist Device) Implantation: This is the most common type of VAD.
      • The main pump unit is typically placed in a pocket created in the abdominal wall or pericardial space, adjacent to the heart.
      • An "inflow cannula" (a tube) is surgically connected to the apex (bottom tip) of the left ventricle. This tube draws blood from the heart into the VAD pump.
      • An "outflow graft" (another tube) is connected from the VAD pump to the ascending aorta (the main artery carrying oxygenated blood from the heart to the body). This tube returns the blood, now pumped by the VAD, back into the circulatory system.
    • RVAD or BiVAD Implantation: In cases requiring support for the right ventricle, an RVAD would be connected from the right ventricle to the pulmonary artery. A BiVAD involves implanting two separate VADs to support both ventricles.
    • Driveline Connection: A small, flexible cable, known as the "driveline," is carefully tunneled through the skin, usually in the upper abdomen, to connect the internal pump to external components. This driveline will exit the body and connect to a portable control unit and battery pack, which the patient will wear continuously. Maintaining the sterility of the driveline exit site is paramount to prevent infection.
  4. Activation and Weaning from Bypass:

    • Once the VAD is securely implanted and all connections are checked, the heart-lung machine is gradually switched off. The VAD is then activated, taking over or assisting the pumping function of the native heart.
    • The surgical team carefully monitors the VAD's function, ensuring optimal blood flow and pressure.
    • Once the VAD is working effectively and the patient's vital signs are stable, the sternum is closed using wires, and the chest incision is sutured. Drains may be placed temporarily to remove any excess fluid.
  5. Post-operative Care:

    • The surgery typically takes 2-4 hours, though it can be longer depending on the complexity of the case.
    • Following surgery, the patient is transferred to the Cardiac Intensive Care Unit (CICU) for close monitoring and recovery. This initial period is critical for managing pain, fluid balance, and ensuring the VAD is functioning correctly.

The VAD procedure represents a significant medical advancement, offering a chance at an extended and improved life for patients with severe heart failure.

Understanding Results

VAD implantation in India has consistently demonstrated promising results, significantly enhancing the quality of life and extending survival for a substantial number of patients. The outcomes are often life-transforming, offering a new lease on life for individuals who previously had very limited options.

  • Improved Survival Rates:

    • Studies and clinical data consistently show that VAD surgery can dramatically improve survival rates for patients with end-stage heart failure. For instance, VAD implantation can effectively double the one-year survival rate compared to conventional medical therapy alone for critically ill patients.
    • Modern VADs, such as the HeartMate 3 device, have shown remarkable longevity and efficacy, with clinical trials demonstrating an impressive 83% two-year survival rate.
    • Many patients with VADs go on to live for several years, with some individuals surviving for over a decade with an LVAD, a testament to the device's durability and the ongoing advancements in patient care. This extended survival provides invaluable time with loved ones and the opportunity to pursue activities once thought impossible.
  • Enhanced Quality of Life:

    • One of the most profound results of VAD implantation is the significant improvement in the patient's quality of life. Before VAD, patients often suffer from debilitating symptoms of heart failure, such as severe fatigue, chronic shortness of breath (dyspnea), swelling in the legs and abdomen (edema), and extreme weakness.
    • Post-VAD, patients typically experience a dramatic reduction in these symptoms. They report increased strength, improved breathing, and significantly enhanced functional capacity, allowing them to resume many daily activities. Many can walk further, perform household chores, engage in hobbies, and even return to work or social events, leading to a much more fulfilling life.
    • The psychological benefits are also substantial, as patients often experience reduced anxiety and depression, improved mood, and a renewed sense of independence and hope.
  • Bridge to Transplant Success:

    • For patients awaiting a heart transplant, VADs serve as an exceptionally effective bridge. They maintain optimal heart function, stabilize the patient's overall health, and prevent the deterioration that can occur during long waiting periods.
    • A high percentage of VAD patients successfully survive to transplant, and their improved physical condition due to VAD support often leads to better outcomes post-transplant. This is particularly crucial in India, where organ donation rates are lower, and waiting lists for heart transplants are lengthy.
  • Heart Recovery (Bridge to Recovery):

    • In a smaller, but significant, number of cases, particularly for patients with acute heart failure from conditions like viral myocarditis or peripartum cardiomyopathy, the VAD can allow the native heart to rest and recover its function.
    • If the heart muscle regains sufficient strength, the VAD can potentially be explanted (removed), a truly remarkable outcome where the patient no longer requires mechanical support. This represents a complete recovery of heart function, although it is a less common result.
  • Long-term Support (Destination Therapy):

    • For patients who are not candidates for heart transplantation, VADs provide effective long-term support as destination therapy. The average life expectancy for patients on destination therapy is around 5 years, with a notable number living for over a decade.
    • This offers a viable and meaningful extension of life, enabling patients to live with improved health and greater independence for many years, a crucial benefit for those who otherwise would have no other treatment options.

Potential Risks and Complications

While VAD implantation offers significant benefits, it is a major surgical procedure and, like all complex medical interventions, carries potential risks and complications. Patients and their families must be fully aware of these possibilities:

  • Infection: This is one of the most significant risks. Infections can occur at the driveline exit site (where the cable exits the skin), around the pump itself, or can become systemic. Meticulous driveline care and strict hygiene are essential to minimize this risk.
  • Bleeding: Both during and after surgery, there is a risk of bleeding. The surgery itself is extensive, and patients are typically on blood-thinning medications (anticoagulants) to prevent clots, which can increase the risk of internal or external bleeding (e.g., gastrointestinal bleeding).
  • Blood Clots and Stroke: As blood flows through the mechanical components of the VAD, there is a risk of blood clot formation. These clots can potentially travel to the brain, leading to a stroke, or cause device malfunction. Lifelong anticoagulation therapy is mandatory to mitigate this risk.
  • Device Malfunction: Although VADs are highly engineered and durable, there is always a possibility of mechanical failure or malfunction of the device, its components, or the batteries. This may necessitate further surgical intervention or device replacement.
  • Right-sided Heart Failure: Following the implantation of an LVAD, the left ventricle's improved pumping action can increase blood flow to the lungs, which can, in turn, put increased strain on the right ventricle. If the right ventricle is already weakened, this can lead to right-sided heart failure, sometimes requiring an RVAD.
  • Arrhythmias: Irregular heartbeats (arrhythmias) are another potential complication, as the heart is already diseased. These may require medication or further interventions like a defibrillator.
  • Kidney or Lung Failure: While less common, severe complications like acute kidney injury or lung failure can occur, particularly in patients with pre-existing organ dysfunction or during complex post-operative recovery.
  • Psychological Impact: Living with a VAD, managing batteries, and adhering to strict routines can be psychologically challenging, leading to anxiety, depression, or body image issues for some patients.

The VAD team provides extensive education and support to help patients and caregivers understand and manage these potential risks, emphasizing the importance of vigilance and prompt reporting of any concerning symptoms.

Costs in India

The cost of VAD implantation in India is a critical consideration for many patients and their families. While it represents a significant investment, the cost is notably lower than in many Western countries, making India an attractive destination for both domestic and international patients seeking advanced cardiac care.

  • General Cost Range:

    • For domestic patients in India, the overall cost of LVAD surgery typically ranges from ₹25,00,000 to ₹50,00,000.
    • For international patients, the cost can range from approximately $30,000 to $75,000 USD, though some estimates suggest an average for LVAD treatment between USD 40,000 and USD 60,000. It is important to note that these figures can vary widely.
  • Specific Device Cost (e.g., HeartMate 3):

    • The newer generation VADs, such as the HeartMate 3, which offers advanced technology and improved outcomes, typically have a higher cost. The average cost for a HeartMate 3 LVAD in India usually ranges from USD 80,000 to USD 100,000. This higher price reflects the sophisticated engineering and clinical benefits of these cutting-edge devices.
  • Factors Influencing the Overall Cost: Several key factors contribute to the total expenditure for VAD implantation:

    • Device Brand and Technology: The choice of VAD brand (e.g., HeartMate II/3, HeartWare HVAD) and its generation significantly impacts the cost. Newer, more technologically advanced devices are generally more expensive but may offer better long-term reliability and fewer complications.
    • Hospital Infrastructure and Reputation: The reputation, accreditation, and advanced infrastructure of the hospital (e.g., state-of-the-art operating theaters, dedicated VAD programs, specialized ICU facilities) play a major role in pricing. Premier cardiac centers in metropolitan areas often have higher costs.
    • Surgeon's Expertise and Experience: Highly experienced and renowned cardiac surgeons specializing in VAD implantation may have higher consultation and surgical fees.
    • City of Treatment: Costs can vary significantly by city due to differences in living costs, hospital competition, and demand for specialized services. For example:
      • Delhi NCR: ₹40,00,000 - ₹50,00,000
      • Mumbai: ₹42,00,000 - ₹52,00,000
      • Bangalore: ₹35,00,000 - ₹45,00,000
    • Pre-operative Evaluation and Heart Failure Management: Extensive diagnostic tests, consultations, and any pre-surgical hospitalization for optimizing heart failure contribute to the initial costs.
    • Post-operative Care and Rehabilitation: This constitutes a substantial portion of the overall expense:
      • ICU Stay: A typical ICU stay of 7-10 days can cost approximately ₹5,00,000 - ₹10,00,000 (or $6,000 - $12,000 USD).
      • General Ward Stay: The subsequent stay in a general ward for several weeks.
      • Rehabilitation: Physical therapy, occupational therapy, and VAD coordinator support for training.
      • Lifelong Medication: Ongoing expenses for anticoagulants (blood thinners), antiarrhythmics, heart failure medications, and other necessary drugs.
      • Follow-up Appointments and Device Management: Regular check-ups with the VAD team, device monitoring, battery replacements, and driveline dressing changes add to the long-term expenses.
    • Complications: Any unforeseen complications, such as infections, bleeding, or device malfunction, will significantly increase the overall cost due to extended hospital stays, additional procedures, and medication.
  • Insurance and Financial Assistance in India:

    • While private health insurance policies in India are slowly starting to recognize and cover advanced cardiac procedures, coverage for VAD implantation can still be limited or require specific riders.
    • Government health schemes often have caps that may not fully cover the high cost of VADs.
    • Many patients rely on personal savings, family support, crowdfunding, or assistance from charitable organizations to manage the financial burden.

Despite the considerable cost, India's medical tourism sector offers competitive pricing, advanced medical facilities, and access to experienced cardiac surgeons, making it a preferred destination for VAD implantation for those seeking world-class treatment at a more accessible price point compared to Western nations.

How Ayu Helps

Ayu, your trusted Indian medical records app, simplifies the complex journey of VAD management by securely storing all your medical history, VAD device specifics, medication schedules, and follow-up appointments, empowering you with organized access and seamless sharing with your care team. It ensures you have critical information at your fingertips for routine management and in emergencies, streamlining communication and improving continuity of care.

FAQ (Frequently Asked Questions)

Q1: What is the average lifespan with a VAD? A: The average lifespan with a VAD varies significantly depending on the patient's overall health, the type of device, and whether it's for bridge-to-transplant or destination therapy. Many patients live for 5-10 years or more with a VAD, with some surviving over a decade.

Q2: Can I live a normal life with a VAD? A: Most patients experience a significant improvement in their quality of life with a VAD. While you won't return to a "pre-heart failure" normal, many can resume daily activities, engage in light exercise, travel, and spend quality time with family. However, certain restrictions, such as avoiding contact sports or swimming, will apply.

Q3: Is VAD reversible? Can it be removed? A: In most cases, a VAD is a long-term implant. However, in rare instances of "bridge-to-recovery" therapy, where the heart muscle significantly recovers its function, the VAD can be surgically removed. This outcome is not common.

Q4: What are the main challenges of living with a VAD? A: The primary challenges include meticulous daily care of the driveline exit site to prevent infection, diligent management of batteries and the control unit, strict adherence to lifelong anticoagulant medication to prevent blood clots, and adapting to the physical presence of the device.

Q5: Is VAD covered by health insurance in India? A: Coverage for VAD implantation in India varies. Some private health insurance policies may cover a portion of the cost, often under specific terms or riders. Government health schemes generally have limits that may not fully cover the high expense. It's crucial to check with your insurance provider well in advance.

Q6: How long is the recovery period after VAD surgery? A: The initial hospital stay after VAD surgery typically ranges from 2 to 4 weeks, including time in the ICU and a general ward. Full recovery and comprehensive rehabilitation, involving physical therapy and VAD management training, can take several months.

Q7: Can I travel with a VAD? A: Yes, traveling with a VAD is generally possible with proper planning. You'll need to carry extra batteries, essential equipment, and your VAD clinic's contact information. Inform your VAD team and airline in advance, and be prepared for airport security screenings.

Q8: What is the difference between an LVAD and a BiVAD? A: An LVAD (Left Ventricular Assist Device) supports only the left ventricle, which pumps blood to the body. A BiVAD (Biventricular Assist Device) is used when both the left and right ventricles are failing and require assistance in pumping blood to both the body and the lungs, respectively. LVADs are far more common.

Continue Reading

More insights on medical records and healthcare technology

Ventricular Assist Device (VAD): Lifesaving Heart Support | Ayu | Ayu - Smart Medical Records for India